Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, FL, NJ, MD, PA, NY · listed Nov 2, 2009 → Jan 8, 2025
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
10 of 42 offerings report sales commissions totalling $4,745,778; 3 report finder's fees totalling $2,350,345; 11 report proceeds to related persons totalling $4,004,390. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jan 8, 2025 D File 021-534510 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 8, 2025 D File 021-534516 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 8, 2025 D File 021-534546 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 7, 2025 D File 021-534380 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 3, 2021 D File 021-391130 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 31, 2018 D File 021-329222 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 18, 2017 D File 021-300967 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 19, 2017 D File 021-297065 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 8, 2017 D File 021-286257 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 16, 2016 D File 021-270815 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 12, 2016 D File 021-270454 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 15, 2015 D File 021-249442 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 30, 2014 D File 021-225481 | $0 | $1,950,345 | $0 | Leerink Partners LLC BrokerCheck CRD 39011 ↗ |
| EDGAR ↗ | Sep 22, 2014 D/A File 021-216434 | $7,500 (est.) | $0 | $0 | Dawson James Securities BrokerCheck CRD 130645 ↗ via Robert Keyser (CRD 1291503 ↗) |
| EDGAR ↗ | Sep 5, 2014 D File 021-224179 | $0 | $0 | $90,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 21, 2014 D File 021-221427 | $0 | $300,000 (est.) | $755,000 | Trout Capital LLC BrokerCheck CRD 131489 ↗ |
| EDGAR ↗ | Feb 3, 2014 D/A File 021-181181 | $0 | $0 | $125,000 (est.) | None listed on this filing |
| EDGAR ↗ | Oct 9, 2013 D File 021-204305 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 1, 2013 D/A File 021-193871 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 1, 2013 D File 021-203783 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 6, 2013 D File 021-202469 | $555,000 (est.) | $0 | $0 (est.) | Maxim Group, LLC BrokerCheck CRD 120708 ↗ |
| EDGAR ↗ | Jun 13, 2013 D File 021-197911 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 22, 2013 D File 021-190575 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 14, 2012 D/A File 021-182440 | $19,000 | $0 | $0 | Jay B. Gutterman BrokerCheck CRD 1109171 ↗ |
| EDGAR ↗ | Nov 23, 2012 D/A File 021-179411 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 12, 2012 D File 021-184023 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 2, 2012 D File 021-180622 | $952,919 (est.) | $0 | $555,000 (est.) proceeds to be used for general corporate purposes including payment of salaries | Maxim Group LLC BrokerCheck CRD 281147 ↗ |
| EDGAR ↗ | Apr 17, 2012 D File 021-176802 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 4, 2012 D File 021-176170 | $2,207,919 (est.) | $0 | $1,074,960 (est.) | Maxim Group LLC BrokerCheck CRD 120708 ↗ |
| EDGAR ↗ | Mar 12, 2012 D/A File 021-169322 | $0 | $0 | $130,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 24, 2012 D File 021-173912 | $0 | $0 | $180,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 24, 2012 D File 021-173914 | $0 | $0 | $170,000 | None listed on this filing |
| EDGAR ↗ | Oct 26, 2011 D File 021-167846 | $150,000 (est.) | $0 | $0 | Equity Source Partners, LLC BrokerCheck CRD 140227 ↗ via Cary W. Sucoff (CRD 1156732 ↗) Dawson James Securities, Inc. BrokerCheck CRD 130645 ↗ |
| EDGAR ↗ | Jul 15, 2011 D File 021-163006 | $0 | $0 | $15,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 6, 2011 D File 021-162380 | $7,500 | $0 | $0 | Adam Stern BrokerCheck CRD 1726306 ↗ via Spencer Trask Ventures, Inc. (CRD 28373 ↗) |
| EDGAR ↗ | Nov 4, 2010 D File 021-150016 | $222,350 (est.) | $0 | $0 (est.) | Maxim Group LLC BrokerCheck CRD 120708 ↗ Equity Source Partners, LLC BrokerCheck CRD 140227 ↗ |
| EDGAR ↗ | Aug 24, 2010 D File 021-146832 | $23,590 (est.) | $0 | $87,100 (est.) | Dawson James Securities Inc. BrokerCheck CRD 130645 ↗ |
| EDGAR ↗ | Aug 12, 2010 D File 021-146335 | $0 | $100,000 (est.) | $0 | Spencer Trask Ventures BrokerCheck CRD 28373 ↗ via Spencer Trask Ventures (CRD 28373 ↗) |
| EDGAR ↗ | Jun 8, 2010 D File 021-143076 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 2, 2010 D File 021-142874 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 11, 2010 D File 021-135770 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2009 D File 021-54183 | $600,000 (est.) | $0 | $822,330 (est.) Payments reflect salary and bonus required to be paid to executive officers pursuant to employment contracts through March 2010. | Newbridge Securities Corporation BrokerCheck CRD 104065 ↗ via Newbridge Securities Corporation (CRD 104065 ↗) |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Evommune, Inc. | Executive Officer, Director | Jan 8, 2025 | D | $115,499,956 similar: $500,000–$7,000,000 | $115,499,956 | 25 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Evommune, Inc. | Executive Officer, Director | Jan 8, 2025 | D | $57,500,000 similar: $500,000–$7,000,000 | $57,500,000 | 16 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Evommune, Inc. | Executive Officer, Director | Jan 8, 2025 | D | $84,449,985 similar: $500,000–$7,000,000 | $81,799,952 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Evommune, Inc. | Executive Officer, Director | Jan 7, 2025 | D | $12,462,474 similar: $500,000–$7,000,000 | $12,462,474 | 18 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Applied UV, Inc. | Director | Mar 3, 2021 | D | $7,122,500 similar: $829,831–$9,999,998 | $7,122,500 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director | Dec 31, 2018 | D | $1,000,000 similar: $829,831–$9,999,998 | $1,000,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director | Dec 18, 2017 | D | $500,000 similar: $829,831–$9,999,998 | $500,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Oct 19, 2017 | D | $28,000,000 similar: $2,000,000–$19,999,994 | $28,000,000 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Avalo Therapeutics, Inc. | Director | May 8, 2017 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $5,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Avalo Therapeutics, Inc. | Director | Sep 16, 2016 | D | $15,000,000 similar: $2,000,000–$19,999,994 | $1,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director | Sep 12, 2016 | D | $1,500,000 similar: $829,831–$9,999,998 | $1,500,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Oct 15, 2015 | D | $3,200,000 similar: $2,000,000–$19,999,994 | $3,200,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director, Promoter | Sep 30, 2014 | D | $50,999,996 similar: $829,831–$9,999,998 | $50,999,991 | 15 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Sep 22, 2014 | D/A | $2,000,000 similar: $829,831–$9,999,998 | $75,000 | 3 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Sep 5, 2014 | D | $1,075,000 similar: $1,100,015–$10,001,163 | $395,000 | 4 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Avalo Therapeutics, Inc. | Director | Jul 21, 2014 | D | $33,259,016 similar: $2,000,000–$19,999,994 | $16,259,016 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Apr 29, 2014 | D | $2,000,000 similar: $829,831–$9,999,998 | $0 | 0 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Feb 3, 2014 | D/A | $2,338,100 similar: $1,100,015–$10,001,163 | $1,263,100 | 21 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Oct 9, 2013 | D | $2,000,000 similar: $829,831–$9,999,998 | $25,000 | 1 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Oct 1, 2013 | D | $2,000,000 similar: $829,831–$9,999,998 | $485,000 | 6 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Oct 1, 2013 | D/A | $1,500,000 similar: $829,831–$9,999,998 | $125,000 | 3 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Avalo Therapeutics, Inc. | Director | Sep 6, 2013 | D | $10,000,000 similar: $2,000,000–$19,999,994 | $6,805,883 | 146 similar: 2–16 | $5,000 similar: $10,000–$50,000 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Jul 10, 2013 | D/A | $2,000,000 similar: $1,100,015–$10,001,163 | $1,263,100 | 21 similar: 2–14 | $53,600 similar: $5,000–$50,000 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director, Promoter | Jun 13, 2013 | D | $25,000,000 similar: $829,831–$9,999,998 | $25,000,000 | 5 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Mar 25, 2013 | D | $1,500,000 similar: $829,831–$9,999,998 | $75,000 | 2 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Jan 22, 2013 | D | $300,000 similar: $829,831–$9,999,998 | $300,000 | 3 similar: 2–15 | $50,000 similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Dec 14, 2012 | D/A | $2,500,000 similar: not enough data | $1,456,086 | 20 similar: not enough data | No minimum reported similar: not enough data |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Nov 23, 2012 | D/A | $2,500,000 similar: $829,831–$9,999,998 | $1,406,086 | 19 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Nov 23, 2012 | D/A | $1,250,000 similar: $829,831–$9,999,998 | $592,500 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Nov 14, 2012 | D/A | $1,500,003 similar: $1,100,015–$10,001,163 | $44,710 | 4 similar: 2–14 | $53,600 similar: $5,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Oct 11, 2012 | D/A | $2,500,000 similar: $829,831–$9,999,998 | $1,122,850 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Dermira, Inc. | Executive Officer, Director, Promoter | Sep 12, 2012 | D | $42,006,739 similar: $829,831–$9,999,998 | $34,006,738 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Aug 9, 2012 | D | $2,500,000 similar: $829,831–$9,999,998 | $774,500 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Jul 13, 2012 | D | $750,400 similar: $1,100,015–$10,001,163 | $44,710 | 4 similar: 2–14 | $53,600 similar: $5,000–$50,000 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Jul 2, 2012 | D | $9,529,382 similar: $2,000,000–$19,999,994 | $9,529,196 | 88 similar: 2–16 | $15,000 similar: $10,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Jun 7, 2012 | D | $1,026,000 similar: $829,831–$9,999,998 | $250,000 | 3 similar: 2–15 | $27,000 similar: $10,000–$54,310 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Apr 17, 2012 | D | $3,000,000 similar: $829,831–$9,999,998 | $297,240 | 15 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Avalo Therapeutics, Inc. | Director | Apr 4, 2012 | D | $22,500,000 similar: $2,000,000–$19,999,994 | $22,137,301 | 156 similar: 2–16 | $24,000 similar: $10,000–$50,000 |
| EDGAR ↗ | First Wave Products Group, LLC group: First Wave | Director | Mar 12, 2012 | D/A | $1,000,000 similar: $1,100,015–$10,001,163 | $130,000 | 3 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | First Wave Products Group, LLC group: First Wave | Director | Feb 24, 2012 | D | $2,000,000 similar: $1,100,015–$10,001,163 | $50,000 | 1 similar: 2–14 | $50,000 similar: $5,000–$50,000 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Feb 24, 2012 | D | $5,025,000 similar: $1,100,015–$10,001,163 | $50,000 | 1 similar: 2–14 | $50,000 similar: $5,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Oct 26, 2011 | D | $1,500,000 similar: $829,831–$9,999,998 | $0 | 0 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | First Wave Technologies, Inc. group: First Wave | Director | Jul 15, 2011 | D | $750,000 similar: $1,100,015–$10,001,163 | $80,000 | 1 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Vyteris, Inc. | Director | Jul 6, 2011 | D | $2,000,000 similar: $829,831–$9,999,998 | $75,000 | 2 similar: 2–15 | $25,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Nov 4, 2010 | D | $4,001,500 similar: $2,000,000–$19,999,994 | $4,001,500 | 17 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | DR. TATTOFF, INC. | Director | Aug 24, 2010 | D | $3,000,000 similar: $829,831–$9,999,998 | $1,261,086 | 15 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | MEDISYNC BIOSERVICES INC | Director | Aug 12, 2010 | D | $1,500,000 similar: $829,831–$9,999,998 | $625,000 | 16 similar: 2–15 | $10,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Jun 8, 2010 | D | $430,370 similar: $2,000,000–$19,999,994 | $430,370 | 11 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | AVC Royalty Fund I, LLC | Director Director of Managing Member | Jun 2, 2010 | D | $2,000,000 similar: $500,000–$7,000,000 | $50,000 | 1 similar: 2–14 | $20,000 similar: $5,000–$50,000 |
| EDGAR ↗ | AVC Royalty Fund I, LLC | Director | Mar 11, 2010 | D | $2,024,100 similar: $500,000–$7,000,000 | $2,024,100 | 10 similar: 2–14 | $20,000 similar: $5,000–$50,000 |
| EDGAR ↗ | AVC Royalty Fund I, LLC | Director Director of Managing Member | Nov 2, 2009 | D | $1,440,000 similar: $500,000–$7,000,000 | $1,440,000 | 5 similar: 2–14 | $20,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Aevi Genomic Medicine, Inc. | Director | Jun 23, 2009 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $265,000 | 5 similar: 2–16 | $50,000 similar: $10,000–$50,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Eugene Bauer. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Eugene Bauer appears on a new Form D, or when a court case or SEC action is matched to them. See plans →